The Degeneration of the Vestibular Efferent Neurons After Intratympanic Gentamicin Administration

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
Qianru WuLijun Pan

Abstract

Intratympanic gentamicin (ITG) has been used to treat refractory Ménière's disease. Disequilibrium after ITG was still a challenge for some patients, and the underlying mechanism is poorly understood. Our previous study demonstrated that gentamicin distributed in the bilateral vestibular efferent neurons (VEN) after ITG; however, does it lead to VEN damage and cause further disequilibrium in patients following ITG? In this study, we observed severe damaged gentamicin-positive neurons of VEN and severe fractured myelin layer plates around neural fibers when viewed under transmission electron microscopy at day 3 after ITG. At day 30, neurons of VEN presented with relatively normal structures. Compared with the control group, the total number of choline acetyltransferase (CHAT) immunolabeling neurons in bilateral VEN showed a significant decrease both at day 3 and day 30. However, there was no significant difference in the total number of CHAT immunolabeling neurons between day 3 and day 30. It indicates that gentamicin is not only retrogradely transported into bilateral VEN, but also results in the degeneration of VEN after ITG. These findings may be related to patients' disequilibrium symptom after ITG. Furthermore, we speculate...Continue Reading

References

Oct 1, 1989·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·S P CassH Goshgarian
Jan 1, 1989·Experimental Brain Research·A A Perachio, G A Kevetter
Jun 19, 1996·Annals of the New York Academy of Sciences·A Lysakowski
Feb 13, 2001·Brain Research·M E ShinderA A Perachio
Jul 1, 1956·The Laryngoscope·H F SCHUKNECHT
Feb 3, 2004·The Laryngoscope·Todd A HillmanMoises A Arriaga
Oct 1, 2004·Journal of Neurophysiology·Timo P HirvonenJohn P Carey
May 16, 2007·Acta Oto-laryngologica·Lieke De BeerHerman Kingma
Jul 3, 2009·Journal of Neurophysiology·Richard BoyleStephen M Highstein
Nov 9, 2010·The Journal of Laryngology and Otology·R C DemarcoM A Hyppolito
Apr 26, 2012·The Annals of Otology, Rhinology, and Laryngology·Jianfen Luo, Lei Xu
Jan 31, 2013·Hearing Research·Erik C Böttger, Jochen Schacht
Nov 2, 2013·Journal of Vestibular Research : Equilibrium & Orientation·Paivi M JordanJ Chris Holt
Jan 31, 2014·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Augusto P CasaniStefano Sellari-Franceschini
Jan 7, 2015·The Journal of Comparative Neurology·Paivi M JordanJoseph C Holt

❮ Previous
Next ❯

Methods Mentioned

BETA
transmission electron microscopy
electron microscopy
light microscopy

Software Mentioned

Photoshop
SPSS
Adobe Illustrator

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India
A K Bhattacharyya
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Stanley ChiaJeffrey P Harris
© 2022 Meta ULC. All rights reserved